Risk of Osteoporosis in Patients with Crohn’s Disease Not Respond to Infliximab Therapy Undergoing Surgical Intervention
Keywords:Osteoporosis, Crohn’s disease, Infliximab, Vitamin D
Osteoporosis is one of the most common complications of Crohn’s disease (CD). Proper history with blood samples were collected from (30) healthy control group, (30) Crohn’s disease patients have been respond to biological therapy ( infliximabIFX) (response group) and (30) CD patients with (non-response group) to biological therapy undergoing surgical intervention for the estimation of some biochemical parameters. This study demonstrate a significant decrease in FGF-23 (fibroblast growth factor 23) and vitamin D Levels between (non- response group) and control group (p< 0.01). Similary , parathyroid hormone (PTH) Levels were increased significantly ( p< 0.01) in (non- response) group. Moreover the calcium (Ca) and phosphours (P) decreased significantly (p< 0.01) in same group. While in CD patients that have been treated with infliximab only vitamin D and FGF 23 decreased significantly (p< 0.01)compared with control group. Levels of Serum FGF23 are considerably lower in CD patients, It is independent pattern was not affected by type of treatment (medical or surgical) . Hypovitaminosis common finding in CD patient’s .Although CD is not disease of vit D deficiency but it clearly is a disease whose pathogenesis seems closely related to vit D Level.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions